Volunteer New York! has announced that seven local volunteers will be honored during its 45th annual Volunteer Spirit Awards ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

The STEM Leadership Center, a Westchester County based nonprofit, in partnership with Regeneron Pharmaceuticals, Inc. and ...

Learn more about whether AbbVie Inc. or Regeneron Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid <li /> If approved, Dupixent would be the ...

Secondly, to support the stock price, Regeneron management announced the authorization of an additional $3 billion, which will go towards a share buyback program. The New York-based company ...

Regeneron Pharmaceuticals ... The company was incorporated in 1988 and is headquartered in Tarrytown, New York. Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based ...

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the ...

which was the sole issue the agency identified when it turned away the Tarrytown, N.Y., biotechnology company's initial application in August. Regeneron, which is seeking FDA approval of ...